Cargando…

TRIM21 chimeric protein as a new molecular tool for multispecies IgG detection

BACKGROUND: The production of monoclonal antibodies for immunoglobulin detection is not cost-effective, while polyclonal antibody production depends on laboratory animals, raising concerns on animal welfare. The widespread use of immunoglobulins in the pharmaceutical industry and the increasing numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Anelize Felicio, Fernandes, Leonardo Antônio, Batista, Franciane, de Souza Vieira, Bianca, Thompson, Mayerson, Mattos, Jacó Joaquim, Marques, Maria Risoleta Freire, de Lourdes Borba Magalhães, Maria, da Silva, Gustavo Felippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334459/
https://www.ncbi.nlm.nih.gov/pubmed/35900674
http://dx.doi.org/10.1186/s43141-022-00396-3
Descripción
Sumario:BACKGROUND: The production of monoclonal antibodies for immunoglobulin detection is not cost-effective, while polyclonal antibody production depends on laboratory animals, raising concerns on animal welfare. The widespread use of immunoglobulins in the pharmaceutical industry and the increasing number and variety of new antibodies entering the market require new detection and purification strategies. The Tripartite motif-containing protein 21 is a soluble intracellular immunoglobulin G receptor that binds to the constant region of immunoglobulin G from various species with high affinity. We hypothesized that using this protein as an antibody-binding module to create immunoglobulin detection probes will improve the portfolio of antibody affinity ligands for diagnostic or therapeutic purposes. RESULTS: We created a chimeric protein containing a mutated form of the C-terminal domain of mouse Tripartite motif-containing protein 21 linked to streptavidin to detect immunoglobulin G from various species of mammals. The protein is produced by heterologous expression and consists of an improved molecular tool, expanding the portfolio of antibody-affinity ligands for immunoassays. We also demonstrate that this affinity ligand may be used for purification purposes since imidazole elution of antibodies can be achieved instead of acidic elution conditions of current antibody purification methods. CONCLUSION: Data reported here provides an additional and superior alternative to the use of secondary antibodies, expanding the portfolio of antibodies affinity ligands for detection and purification purposes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43141-022-00396-3.